Ashwagandha Adulteration: How HPTLC and DNA Barcoding Catch What Your Supplier's COA Misses

Approximately 5 grams of ashwagandha root powder looks identical whether it came from certified Withania somnifera root or a blend of Withania coagulans leaf and maltodextrin filler. Your supplier’s COA won’t tell you which one you received.

That’s not a hypothetical. It’s a recurring pattern our team sees in incoming botanical raw material lots — especially since global ashwagandha demand surged past $600 million in annual sales and Indian export volumes scaled to meet it. When market pressure pushes volume over quality, species substitution and potency manipulation follow. And the brands absorbing that risk are the supplement manufacturers who trusted a PDF.

For Chicago-area and Midwest supplement brands sourcing ashwagandha from international suppliers, understanding what adulteration actually looks like — and what methods can reliably detect it — is increasingly a compliance requirement, not just a quality preference.

The Ashwagandha Adulteration Problem, Specifically

Ashwagandha is now the dominant adaptogen in the US supplement market, and the global market is projected to reach $1.5 billion by 2030, driven almost entirely by North American and European consumer demand. The majority of the world’s commercial crop is grown in Rajasthan, Madhya Pradesh, and Uttar Pradesh. The supply chain between Indian farms and a Midwest contract manufacturer passes through multiple intermediary steps — brokers, processors, export agents — at every one of which substitution can occur and often goes undetected.

The adulteration patterns we encounter fall into three categories.

Species substitution. Withania coagulans, sometimes called Indian rennet or paneer dodi, is botanically related to W. somnifera but carries a meaningfully different phytochemical profile. It commands roughly 30–40% lower pricing at the farmgate level. A COA listing “Withania somnifera root extract” produced by a supplier using only HPLC marker compound testing may not flag this substitution if withanolide peaks overlap within the method’s tolerance window.

Leaf adulteration. Traditional ashwagandha root is the pharmacopoeially recognized and commercially premium part. Leaf material is significantly cheaper. It also contains higher alkaloid content but lower and differently distributed withanolide content compared to root. Blending leaf into root powder to increase weight — or to inflate certain HPLC peaks — is a documented practice in the supply chain. The American Herbal Pharmacopoeia (AHP) monograph for W. somnifera explicitly distinguishes root from leaf. Specifications referencing root should reflect root anatomy, something HPTLC can confirm and a bulk withanolide HPLC assay cannot.

Marker compound manipulation. HPLC-based withanolide quantification is the industry norm, with authenticated products typically standardized to 2.5–5% withanolide content by weight. But isolated withanolide standards are commercially available, and spiking diluted or low-quality base material to hit a withanolide specification is technically straightforward. An HPLC method that only reports total withanolide content won’t detect this. It will produce a passing value on a failing product.

What a Supplier COA Actually Certifies

A typical ashwagandha extract COA covers appearance, color, odor, mesh size, moisture content, heavy metals, microbiology, pesticide residues, and an HPLC withanolide assay. That’s a reasonable battery of tests. But there’s a structural limitation every buyer should understand: every test on that COA was performed by the supplier’s own lab or a contracted lab of their choosing, using their own retained reference standards.

There is no regulatory requirement under Indian export manufacturing that a COA be issued by an ISO/IEC 17025-accredited facility. There is no independent verification that the identity test — if one was performed at all — used a pharmacopoeial reference standard. A COA is a document; it is not an independent test result.

21 CFR Part 111.75(a)(1) addresses this directly: “Before you use a component, you must conduct at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient.” The FDA’s consistent interpretation is that your firm must perform the identity test — or must have documented validation that supplier testing constitutes a sufficient and qualified surrogate. Relying solely on a supplier COA does not satisfy that requirement, and the FDA has cited firms for exactly this in 483 observations and warning letters.

Closing the gap between what a COA says and what your identity test program requires is exactly where adulteration survives undetected. Bridging it requires methods built to answer the right question: is this actually Withania somnifera root?

HPTLC: Why Botanical Fingerprinting Works Where HPLC Doesn’t

High-performance thin-layer chromatography (HPTLC) is the identity method referenced in USP <203> and in AHP monographs for botanical identity confirmation. It’s accurately described as a fingerprint method: the chromatographic pattern generated by a botanical extract reflects dozens of individual compounds simultaneously, producing a visual and densitometric profile characteristic of both the species and the plant part.

For W. somnifera root, a validated HPTLC method develops a characteristic withanolide band pattern at specific Rf values under UV 366nm and under visible light after anisaldehyde-sulfuric acid derivatization. Withania coagulans produces a visually distinct pattern — one a trained analyst can differentiate from an authentic W. somnifera root reference standard run in the same plate. Leaf material from W. somnifera produces a different band distribution than root, directly reflecting the different phytochemical composition between plant parts.

What HPTLC does not do is quantify marker compound content — that remains the role of HPLC or UV-Vis assay. HPTLC answers the identity question; HPLC answers the potency question. A compliant raw material program uses both.

The cost arithmetic is clear. An HPTLC identity test for ashwagandha runs roughly $150–$250 per lot at a qualified lab. For a brand receiving 12 lots per year, that’s $1,800–$3,000 in annual identity testing spend. Against the cost of a single FDA 483 observation, a batch recall, or a customer adverse event, that number isn’t even worth debating.

DNA Barcoding as a Second Line of Defense

DNA barcoding has become a credible tool in botanical identity since the 2013 Newmaster et al. study in BMC Medicine, which identified species substitution in approximately 59% of herbal products tested by ITS2 and rbcL gene sequencing. The method amplifies and sequences a short, conserved gene region — typically the ITS2 (internal transcribed spacer 2) region for flowering plants — and compares it against a reference database to confirm species identity at the genus and species level.

For ashwagandha root powder, DNA barcoding is most reliable when material is minimally processed. Powdered root retains usable DNA for PCR amplification. Highly processed extracts — particularly those that have undergone high-temperature spray drying, solvent-based concentration, or extreme pH treatment — may show DNA degradation that limits method performance. In those cases, HPTLC remains the primary identity tool.

Where DNA barcoding adds genuine value is in confirming species identity when HPTLC patterns are ambiguous due to unusual extraction processes, and in detecting adulteration from non-Withania species that might produce a visually similar chromatogram to an inexperienced analyst. We recommend running both methods on initial supplier qualification — typically the first 2–3 lots from a new supplier — then maintaining an HPTLC-based lot-release program with periodic DNA confirmation.

DNA barcoding runs $200–$400 per sample at specialized facilities, which is modestly higher than HPTLC. But for the qualification phase, where you’re making a long-term sourcing decision, it’s a reasonable addition.

What 21 CFR Part 111 Demands — and Where Most Brands Still Fall Short

The GMP requirements under 21 CFR Part 111 are specific about incoming material testing. Section 111.70 requires that component specifications be established. Section 111.75(a)(1) requires identity testing before use. Section 111.75(h) requires that you retain documentation of every identity test result by lot.

What this means operationally: you need a written identity testing SOP, a qualified test method with documented reference standard provenance, a specification that explicitly calls for species identity confirmation (not just marker compound content), and lot-level records maintained in your batch record system. Scanning and filing the supplier’s COA does not satisfy any of these requirements individually.

The practical qualification checklist for an ashwagandha raw material program looks like this. Establish a written specification that references W. somnifera root part, confirmed by HPTLC against AHP or USP reference standards. Run HPTLC on every incoming lot and retain the plate photograph and densitogram in the lot file. Run DNA barcoding (ITS2 method) on every new supplier’s first three lots, and on any lot producing an anomalous HPTLC pattern. Document the test method version, analyst, equipment, and reference standard lot for each test. Link every test result to the corresponding batch production record by lot number.

For brands receiving more than 20 botanical raw material lots per year, a tiered supplier qualification program — with reduced lot-level testing for pre-qualified, audited suppliers and full panel testing for new suppliers or after any supply chain change — is more cost-effective and still defensible in an FDA inspection.

The Midwest Logistics Reality

Most ISO 17025-accredited labs with validated HPTLC and DNA barcoding capability for botanicals are on the coasts. Shipping samples to California or New Jersey, then waiting 10–14 business days for results, creates genuine friction in procurement and batch release workflows for Chicago-area manufacturers.

That’s the problem Ayah Labs’ Countryside, IL receiving facility addresses. Samples ship to our Chicago-area hub — a short drive from the majority of the region’s supplement contract manufacturing corridor — and we coordinate forward handling to the Qalitex ISO 17025-accredited California laboratory for HPTLC identity testing, DNA barcoding, HPLC withanolide assay, heavy metals (USP <232>/<233>), and microbiology (USP <61>/<62>). A complete botanical raw material panel returns a Qalitex-issued COA in 5–7 days.

That’s a meaningful turnaround improvement against traditional direct-to-coast shipping, and the accredited COA you receive is the documentation your quality system — and any GMP audit — expects to see behind an identity testing claim.

If your ashwagandha supplier’s COA is the only thing standing between your quality system and an adulteration event, the gap in your program is already larger than you think. HPTLC and DNA barcoding exist precisely to close it — and the regulatory requirement to do so is already written into the GMP rule.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days Contact us

Related from our network

• ISO 17025 Supplement Testing — Qalitex Laboratories — Accredited COA issuance for dietary supplement and botanical raw material testing, including HPTLC identity, ICP-MS heavy metals, and USP microbiology panels.
• Botanical Identity Testing Methods — Qalitex Laboratories — How Qalitex’s California lab applies HPTLC fingerprinting and DNA barcoding to confirm species identity for herbal supplement brands nationwide.